LadRx (STU:CX5) Accounts Payable : €1.10 Mil (As of Dec. 2023)

View and export this data going back to 1986. Start your Free Trial

What is LadRx Accounts Payable?

LadRx's Accounts Payable for the quarter that ended in Dec. 2023 was €1.10 Mil.

LadRx's quarterly Accounts Payable declined from Jun. 2023 (€0.97 Mil) to Sep. 2023 (€0.93 Mil) but then increased from Sep. 2023 (€0.93 Mil) to Dec. 2023 (€1.10 Mil).

LadRx's annual Accounts Payable declined from Dec. 2021 (€1.30 Mil) to Dec. 2022 (€0.92 Mil) but then increased from Dec. 2022 (€0.92 Mil) to Dec. 2023 (€1.10 Mil).

LadRx Accounts Payable Historical Data

The historical data trend for LadRx's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LadRx Accounts Payable Chart

LadRx Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.80

1.15

1.30

0.92

1.10

LadRx Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															0.92	1.05	0.97	0.93	1.10

LadRx Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

LadRx Accounts Payable Related Terms

Thank you for viewing the detailed overview of LadRx's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

LadRx (STU:CX5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LadRx Corp (STU:CX5) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

LADX:USA

Address

11726 San Vicente Boulevard, Suite 650, Los Angeles, CA, USA, 90049

Website

https://www.ladrxcorp.com

LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.

LadRx (STU:CX5) Headlines

No Headlines